SHINE Technologies, LLC; SHINE Medical Isotope Production Facility
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The U.S. Nuclear Regulatory Commission (NRC) is considering issuance of an amendment to Construction Permit No. CPMIF-001, issued to SHINE Technologies, LLC (SHINE, the licensee), for the construction of the SHINE Medical Isotope Production Facility. The proposed amendment would allow the receipt and possession of contained special nuclear material for the continued construction of the SHINE Medical Isotope Production Facility.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.